Stay Connected with Us
Main
Company
What we do
History
Our Team
Board of Directors
Management
Engineering
Clinical Board
Electrophysiology Team
Regulatory Affairs
Electrophysiology Board
Neurological Board
Corporate Partners
Technology
CGCI
Overview
Studies
Applications
Installations
Tools
Patents
Media
Publications
Conferences
Investor Relations
News
Contact
News Articles
Magnetecs CGCI Robotic Ablation Procedure Presented At Boston AF Symposium
Magnetecs CGCI Receives CE Marking for Sales in Europe
Information on Magnetecs CGCI Commercialization Strategy
Magnetecs Creates International Marketing Division Under Vice Chairman Eytan Lombroso
Magnetecs Sells Robotic Catheter Guidance System to Yonsei University Severance Hospital in Korea
Dr. Eli Gang ranked among America's Best Doctors
CGCI Published in the Circulation Journal of American Heart Association
Research Results and “Live Case” Using the Magnetecs Robotic Catheter Guidance System to be Presented at EHRA Europace Conference in Madrid
Magnetecs to present CGCI to International Congress
Clive Zickel Joins Magnetecs As Chief Financial Officer
Operating on the Heart with a 'Joystick'
Robotic Catheterization for Cardiac Arrhythmias
Magnetecs Engages Dr. Alexander Fleming for U.S. Regulatory Affairs
Three Patents Issued to Magnetecs in January 2011
Magnetecs Recieves Grants Totaling $626,000 for Remote Navigation Systems
Interim Results of Human Studies Using Magnetecs CGCI Robotic Catheter Guidance System to be Presented at Conferences in London and Tel Aviv
Human Studies Commence Using Magnetecs Robotic Catheter Guidance System
President of Madrid Inaugerates Magnetecs EP Lab in Spain
La Paz, primer centro del mundo con una sala robotizada para cateterismos [Spanish]
La Paz, pionero en medicina cardiológica robotizada [Spanish]
Contact Information
10524 La Cienega Blvd
Inglewood, California, 90304
Tel: 310.670.7700
Contact email
technical support
sales and marketing
engineering
News article not found.
Index
News
©2010-2024 Magnetecs - All Rights Reserved |
Privacy Policy
|
Terms of Use
|
Company
|
Technology
|
Media
|
Publications
|
Investor Relations
|
News
|
Contact Us